Howard Marks Alvotech Transaction History
Oaktree Capital Management LP
- $3.91 Billion
- Q4 2024
A detailed history of Howard Marks (Oaktree Capital Management LP) transactions in Alvotech stock. As of the latest transaction made, Oaktree Capital Management LP holds 1,925,705 shares of ALVO stock, worth $22.1 Million. This represents 0.65% of its overall portfolio holdings.
Number of Shares
1,925,705
Previous 2,532,027
23.95%
Holding current value
$22.1 Million
Previous $30.1 Million
15.64%
% of portfolio
0.65%
Previous 0.64%
Shares
9 transactions
Others Institutions Holding ALVO
# of Institutions
44Shares Held
14.5MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA3.2MShares$36.6 Million0.0% of portfolio
-
Bracebridge Capital, LLC2.71MShares$31 Million5.53% of portfolio
-
Morgan Stanley New York, NY1.48MShares$17 Million0.0% of portfolio
-
Littlejohn & CO LLC1.32MShares$15.1 Million7.91% of portfolio
-
Point State Capital LP New York, NY1.24MShares$14.2 Million0.37% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $2.85B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...